145
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis, Antimicrobial Evaluation, and Docking Studies of Substituted New Chromone Linked 1,2,3-Triazoles

ORCID Icon, , , , , & ORCID Icon show all
Pages 3927-3944 | Received 25 Jan 2023, Accepted 21 Jul 2023, Published online: 02 Aug 2023
 

ABSTRACT:

In Search of new antibacterial, antifungal agents with improved potency, herein we report the synthesis of a series of new substituted 2-(4-fluorophenyl)-3-((1-phenyl-1H-1,2,3-triazol-4-yl)methoxy)-4H-chromen-4-one derivatives (6a‐q), starting from acetophenone. All the synthesized compounds have been screened for in vitro antibacterial and antifungal activity by using the agar well diffusion method. Among fifteen synthesized compounds, four chromone derivatives i.e. (6a-b), (6h), and (6i) have shown proficient antimicrobial activities. Compound (6a) showed powerful inhibitory activity against all bacterial pathogens but it was not that effective against fungal pathogens on the other hand compound (6b) showed satisfactory activity against fungal pathogens as well. The activity of compounds (6h) and (6i) against S. aureus was remarkable. Other compounds were found active against a few pathogens but activity was good. The compound (6b) was found very effective in inhibiting the growth of S. aureus ATCC 6538 at a low concentration with MIC 190 µg/ml.

Graphical abstract

Acknowledgments

The author A.S.N. is very grateful to the Head of the Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, for providing the necessary laboratory facilities to carry out the work. We are also thankful to Dr. Babasaheb Ambedkar Marathwada University Sub-campus, Osmanabad for providing biological activity. We are also thankful to SAIF, CSIR-CDRI, Lucknow, and BITS-Pilani, India. For providing spectral analysis data.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.